Combinatorial approaches to inhibitors of VLA-4: piperazine-peptoid-bisarylureas.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 11865647)

Published in Mol Divers on January 01, 2000

Authors

I Lewis1, B Rohde, M Mengus, M Weetall, S Maida, R Hugo, P Lake

Author Affiliations

1: Transplantation Research Chemistry Unit, S-507.3.03, Novartis Pharma, CH-4002 Basel, Switzerland. ian.lewis@pharma.novartis.com

Articles by these authors

Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem (2000) 6.87

Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther (1969) 4.24

Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature (1982) 2.84

Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol (1982) 2.30

Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis. SAR QSAR Environ Res (2004) 2.23

Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets. Eur J Immunol (1979) 2.20

Antigen-specific human T lymphocyte clones: viral antigen specificity of influenza virus-immune clones. J Immunol (1982) 1.49

Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. J Natl Cancer Inst (1987) 1.42

Case report: implants as anchorage for molar uprighting and intrusion. Angle Orthod (1996) 1.39

Wavelength-dependent measurements of optical-fiber transit time, material dispersion, and attenuation. Appl Opt (2001) 1.39

Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harb Symp Quant Biol (1977) 1.37

Cystic meningioma. Case report. J Neurosurg (1973) 1.33

Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrob Agents Chemother (1995) 1.25

Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses. J Exp Med (1985) 1.10

Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion. Protein Eng (2001) 1.07

The dissociation of interleukin-2 production and antigen-specific helper activity by clonal analysis. Immunology (1983) 1.04

SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones. Nature (1983) 1.02

Recognition and genetic control of helper determinants for cell surface antigen Thy-1. Nature (1978) 1.00

Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol (2007) 0.95

[Studies on the sensitivity to irradiation of the Harding-Passey mouse melanoma]. Arch Klin Exp Dermatol (1966) 0.94

A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal Biochem (2001) 0.93

Urethral adenocarcinoma (possibly originating in the glands of Littre). J Urol (1975) 0.92

[Peritoneal deciduosis: cause for mechanical ileus in pregnancy]. Geburtshilfe Frauenheilkd (1991) 0.91

Inhibition of T cell proliferation by antibodies to synthetic peptides. Eur J Immunol (1984) 0.91

A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor. J Pharmacol Exp Ther (2001) 0.90

Cloned measles virus-specific T lymphocytes from a twin with multiple sclerosis. Proc Natl Acad Sci U S A (1983) 0.90

Cytotoxic and fluorescent assays for thymocyte subpopulations differing in surface thy-1 level. Cell Biophys (1979) 0.89

The fine structure of Leucocytozoon simondi. I. Gametocytogenesis. Can J Zool (1970) 0.88

Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes. Hum Immunol (1982) 0.88

Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin. J Pharmacol Exp Ther (1990) 0.87

Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens. J Immunol (1984) 0.86

Functional interactions of human and murine lymphoid cells. I. Analysis of primary and secondary responses. Cell Immunol (1986) 0.85

The use of artificial diets to determine some of the effects of Nocardia rhodnii on the development of Rhodnius prolixus. J Insect Physiol (1968) 0.85

Screening for middle-ear disease in schools for hearing-impaired children. Int J Pediatr Otorhinolaryngol (1989) 0.84

Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics. Eur J Clin Pharmacol (2000) 0.84

Viral antigens act as helper determinants for antibody responses to cell surface antigens. J Immunol (1982) 0.84

Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo. Immunology (1974) 0.84

A new cross-correlation algorithm for the analysis of "in vitro" neuronal network activity aimed at pharmacological studies. J Neurosci Methods (2011) 0.84

Sudden hemorrhage in metastatic thyroid carcinoma of the brain during treatment with iodine-131. J Nucl Med (1976) 0.84

Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. J Clin Pharmacol (1997) 0.83

Alteration of the nuclear pore complex in Ca(2+)-mediated cell death. Cell Death Differ (2010) 0.83

A novel subset of antigenic cells triggers B-cell responses to MHC antigens. Nature (1979) 0.82

A sensitive assay for transplantation immunity in mice. Transplant Proc (1971) 0.82

Validation of 1-year predictive score of long-term response to interferon-β in everyday clinical practice multiple sclerosis patients. Eur J Neurol (2015) 0.82

Associative control of the immune response to cell surface antigens. Immunol Commun (1976) 0.81

A high-capacity alkaline phosphatase reporter system for the rapid analysis of specificity and relative affinity of peptides from phage-display libraries. J Immunol Methods (2001) 0.81

Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein. Biotechnol Appl Biochem (2001) 0.81

Binding epitope of somatostatin defined by phage-displayed peptide libraries. Biotechnology (N Y) (1995) 0.81

Recombinant human IgG1-murine IgE chimeric Ig. Construction, expression, and binding to human Fc gamma receptors. J Immunol (1990) 0.81

Can social bees be influenced to choose a specific feeding station by adding the scent of the station to the hive air? J Chem Ecol (1995) 0.80

Modulation of Thy-1 alloantibody responses: donor cell-associated H-2 inhibition and augmentation without recipient Ir gene control. J Immunol (1981) 0.80

Demonstration with monoclonal antibody of the glycoprotein nature of Thy-1.2 alloantigen. Can J Biochem (1980) 0.80

FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model. Transplant Proc (2001) 0.80

Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity. Immunology (1974) 0.79

Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins. Mol Immunol (2001) 0.79

Early identification of at-risk infants and toddlers: a transdisciplinary model of service delivery. S Afr J Commun Disord (2000) 0.79

Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. Am J Vet Res (1999) 0.79

Human iliac vein replacement with a tissue-engineered graft. Vasa (2009) 0.79

Design and synthesis of potent and selective inhibitors of integrin VLA-4. Bioorg Med Chem Lett (2001) 0.78

Intact and subcellular form of thymocytes of rats are exceptionally immunogenic in mice for inducing anti-Thy-1 T cell-independent class 2 antibody responses. Immunol Lett (1983) 0.78

Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix. Eur J Vasc Endovasc Surg (2008) 0.78

T-cell replacing factor activity of recombinant-derived interleukin-2 requires gamma-interferon. J Interferon Res (1986) 0.78

Primate antibodies to components of the human immune system. J Med Primatol (1994) 0.77

Antibody response induced in vitro to the cell-surface alloantigen Thy-1. Nature (1976) 0.77

Excess cerumen: failure rate of black and Indian preschool children from Durban on the Middle Ear Screening Protocol (MESP). S Afr J Commun Disord (1997) 0.77

[Diagnostic pitfalls apropos of a case of acoustic neurinoma: pre- and postoperative considerations]. Rev Otoneuroophtalmol (1966) 0.76

[Electronystagmographic study of the phenomenon of vestibular compensation with the aid of the rotatory pendulum test]. Pract Otorhinolaryngol (Basel) (1966) 0.75

Field studies with thiophanate given as a 14-day low level in-feed anthelmintic to pigs. Vet Rec (1979) 0.75

Communication skills of biologically at-risk neonates. S Afr J Commun Disord (1995) 0.75

[The Polygone School, "Section of the motor-handicapped". Its place in the education of young-motor-handicapped individuals]. Strasb Med (1965) 0.75

[Written and spoken Afrikaans syntax abilities of hearing impaired children]. S Afr J Commun Disord (1987) 0.75

[The occurrence of communicative acts of preschool Afrikaans-speaking hearing-impaired children ]. S Afr J Commun Disord (1991) 0.75

Speech and hearing therapists; communication savers? SA Nurs J (1977) 0.75

Evidence for the erythrocyte as the principal antigenic cell type that triggers primary IgM antibody responses to H-2D alloantigens. Transplantation (1983) 0.75

Speech production changes with the Nucleus 22-channel cochlear implant. Ann Otol Rhinol Laryngol Suppl (1995) 0.75

Acoustic Detection of Rhynchophorus ferrugineus (Coleoptera: Dryophthoridae) and Oryctes elegans (Coleoptera: Scarabaeidae) in Phoenix dactylifera (Arecales: Arecacae) Trees and Offshoots in Saudi Arabian Orchards. J Econ Entomol (2016) 0.75

An expanded Aboriginal medical service in Adelaide. Australas Nurses J (1979) 0.75

[Perceptual abnormalities in dysphemia]. J S Afr Speech Hear Assoc (1972) 0.75

[Hearing tests in infant clinics a possibility?]. SA Nurs J (1977) 0.75

[Urological problems of meningomyelocele (12 cases)]. J Urol Nephrol (Paris) (1970) 0.75

Pharmacokinetic studies of oral and intravenous cyclosporine in prekidney transplant patient. Transplant Proc (1998) 0.75

[The influence of otitis media on the central auditory abilities of children with sensory integration problems]. S Afr J Commun Disord (1990) 0.75

[Psoriasis in children]. Krankenpflege (Frankf) (1982) 0.75

[Hemifacial contracture and glioma of the brain stem: clinical and electromyographic data in 2 cases]. Rev Otoneuroophtalmol (1978) 0.75

[Regulatory framework of innovative therapies : From bench to bedside]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.75

Speech production changes with the use of a multichannel cochlear implant in a postlingually hearing impaired adult. S Afr J Commun Disord (1994) 0.75

[Apropos of a primary cholesteatoma of the petrous bone]. Rev Otoneuroophtalmol (1966) 0.75

I-J restriction of T cells that suppress in vivo antibody responses to Thy-1. J Immunol (1982) 0.75

[Toxic trigeminal disease and polyvinylidene chloride]. Rev Otoneuroophtalmol (1971) 0.75

Prediction of in vivo drug interaction from in vitro systems exemplified by interaction between verapamil and cimetidine using human liver microsomes and primary hepatocytes. J Clin Pharmacol (1997) 0.75

[Hearing ability for auditory-linguistic stimuli in the 1st year]. S Afr J Commun Disord (1982) 0.75